Table 2.
Groups and rate difference | CO-validated continuous abstinence (intention to treat) | CO-validated continuous abstinence (per protocol) |
Control group, n/N (%) | 51/271 (18.8) | 51/128 (39.8) |
Intervention group, n/N (%) | 63/242 (26.0) | 63/104 (60.6) |
Rate difference (95% CI) | –7.2 (–14.4 to 0.0) | –20.7 (–33.4 to –8.1) |
Odds ratio raw (95% CI) | 1.5 (1.0 to 2.3) | 2.3 (1.4 to 3.9) |
P value | .05 | <.001 |
Odds ratio adjusted (95% CI)a | 1.52 (0.99 to 2.33) | 2.35 (1.37 to 4.05) |
P value | .05 | .002 |
aAdjusted by baseline CO-oximetry and bupropion intake.